{"id":9930,"date":"2024-05-19T17:05:00","date_gmt":"2024-05-19T09:05:00","guid":{"rendered":"https:\/\/ttic.nhri.edu.tw\/?p=9930"},"modified":"2025-05-19T17:05:58","modified_gmt":"2025-05-19T09:05:58","slug":"2024-usbio-spot-light-of-recent-invention-2024-06-01","status":"publish","type":"post","link":"https:\/\/ttic.nhri.edu.tw\/en\/2024-usbio-spot-light-of-recent-invention-2024-06-01\/","title":{"rendered":"2024 USBio- Spot Light of Recent Invention (2024\/06\/01)"},"content":{"rendered":"\r\n\r\n<span style=\"color: #0070c0;\"><strong><u>Cancer<\/u><\/strong><\/span>\r\n<ol>\r\n \t<li><strong>BPR5K230<\/strong>\/ Small Molecule <span style=\"color: #0070c0;\"><strong>AXL and MERTK<\/strong><\/span> Dual Kinase Inhibitor as Anticancer and Immunomodulatory Agent<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstract-BPR5K230.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-BPR5K230.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"2\">\r\n \t<li><strong>DBPR117<\/strong>\/ A Monoclonal Antibody Targeting <strong><span style=\"color: #0070c0;\">RSPO3\/Wnt <\/span><\/strong><span style=\"color: #0070c0;\"><span style=\"color: #000000;\">Signaling &#8211; Mediated Tumorigenesis<\/span><\/span><\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstrat-DBPR117.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-DBPR117.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"3\">\r\n \t<li><strong>DBPR728<\/strong>\/ A Kinase Inhibitor Targeting<strong><span style=\"color: #0070c0;\"> MYC<\/span><\/strong> Driven Cancers- A precision medicine strategy for cancers<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstract-DBPR728.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-DBPR728.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"4\">\r\n \t<li><span style=\"color: #000000;\"><strong>DBPR807<\/strong><\/span>\/ A <strong><span style=\"color: #0070c0;\">CXCR4<\/span><\/strong>-Targeted Antagonist- Therapeutic Application of CXCR4 Antagonist DBPR807 Combined with Sorafenib in HCC<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstract-DBPR807.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-DBPR807.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"5\">\r\n \t<li><strong>DBPR22998<\/strong>\/ <span style=\"color: #0070c0;\"><strong>A Potent QPCTL (IsoQC) <\/strong><\/span>Inhibitor Targeting CD47-SIRP\u03b1 Axis for Cancer Immunotherapy<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstract-DBPR22998.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-DBPR22998.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"6\">\r\n \t<li><strong>NTSR1Ab<\/strong>\/A novel antibody-drug conjugate (ADC)\r\ntargeting cancers expressing <span style=\"color: #0070c0;\"><strong>neurotensin receptor 1 (NTSR1)<\/strong><\/span><\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstract-NTSR1Ab.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-NTSR1Ab.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<span style=\"color: #0070c0;\"><strong><u>CNS<\/u><\/strong><\/span>\r\n<ol>\r\n \t<li>Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/05\/2024USBIO-abstract-Method-and-composition-for-decreasing-the-side-effect-and-addictive-disorder-of-ketamine.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/05\/2024USBIO-ppt-Method-and-composition-for-decreasing-the-side-effect-and-addictive-disorder-of-ketamine.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"2\">\r\n \t<li><strong>BPR1M492<\/strong>\/ A <span style=\"color: #0070c0;\"><strong>MOR\/NOP<\/strong> <\/span>Dual Agonist as a Safe Pain Killer- Novel and Fast Acting Opioid Analgesic<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/05\/2024USBIO-abstract-BPR1M492.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/05\/2024USBIO-ppt-BPR1M492-final-20240530.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"3\">\r\n \t<li><strong>DBPR116<\/strong>\/ An Antagonist-to-Agonist Allosteric Modulator- <strong><span style=\"color: #0070c0;\">Pain Relief<\/span> <\/strong>Agent with Limited Side Effects of Opioids<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/05\/2024USBIO-abstract-DBPR116.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/05\/2024USBIO-ppt-DBPR116_20240531.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"4\">\r\n \t<li>Cutting Alzheimer\u2019s Risk by 45%: Explore Our Innovative Pharmaceutical Combination Therapy<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/05\/2024USBIO-abstract-Cutting-Alzheimers-Risk-by-45-Explore-Our-Innovative-Pharmaceutical-Combination-Therapy.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/05\/2024USBIO-ppt-Cutting-Alzheimers-Risk-by-45-Explore-Our-Innovative-Pharmaceutical-Combination-Therapy.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<span style=\"color: #0070c0;\"><strong><u>Vaccines<\/u><\/strong><\/span>\r\n<ol>\r\n \t<li>A broad-spectrum pneumococcal vaccine<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstract-A-broad-spectrum-pneumococcal-vaccine.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-A-broad-spectrum-pneumococcal-vaccine.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<ol start=\"2\">\r\n \t<li>FLIPr-Mediated Antigen Targeting to Dendritic Cells<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstract-FLIPr-Mediated-Antigen-Targeting-to-Dendritic-Cells.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-FLIPr-Mediated-Antigen-Targeting-to-Dendritic-Cells.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n<span style=\"color: #0070c0;\"><strong><u>Platform<\/u><\/strong><\/span>\r\n<ol>\r\n \t<li>Novel Therapeutic <span style=\"color: #0070c0;\"><strong>Inducible Exosome (iExo)<\/strong><\/span> Platform for Regenerative Medicine<\/li>\r\n<\/ol>\r\n<ul>\r\n \t<li>Abstract\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-abstract-iExo.pdf\">Click here<\/a><\/li>\r\n \t<li>PowerPoint\uff1a<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2024\/04\/2024USBIO-ppt-iExo.pdf\">Click here<\/a><\/li>\r\n<\/ul>\r\n","protected":false},"excerpt":{"rendered":"<p>Cancer BPR5K230\/ Small Molecule AXL and MERTK Dual Kinase Inhibitor as Anticancer and Immunomodulatory Agent Abstract\uff1aClick here PowerPoint\uff1aClick here DBPR117\/ A Monoclonal Antibody Targeting RSPO3\/Wnt Signaling &#8211; Mediated Tumorigenesis Abstract\uff1aClick here PowerPoint\uff1aClick here DBPR728\/ A Kinase Inhibitor Targeting MYC Driven Cancers- A precision medicine strategy for cancers Abstract\uff1aClick here PowerPoint\uff1aClick here DBPR807\/ A CXCR4-Targeted Antagonist- &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/ttic.nhri.edu.tw\/en\/2024-usbio-spot-light-of-recent-invention-2024-06-01\/\"> <span class=\"screen-reader-text\">2024 USBio- Spot Light of Recent Invention (2024\/06\/01)<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[221],"tags":[],"table_tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/9930"}],"collection":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/comments?post=9930"}],"version-history":[{"count":1,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/9930\/revisions"}],"predecessor-version":[{"id":9931,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/9930\/revisions\/9931"}],"wp:attachment":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/media?parent=9930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/categories?post=9930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/tags?post=9930"},{"taxonomy":"table_tags","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/table_tags?post=9930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}